nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—CUBN—melanoma	0.718	1	CbGaD
Hydroxocobalamin—Cyanocobalamin—CUBN—melanoma	0.00647	1	CrCbGaD
Hydroxocobalamin—MUT—hair follicle—melanoma	0.00321	0.09	CbGeAlD
Hydroxocobalamin—Infusion site reaction—Docetaxel—melanoma	0.00306	0.0456	CcSEcCtD
Hydroxocobalamin—Folliculitis—Vemurafenib—melanoma	0.00221	0.033	CcSEcCtD
Hydroxocobalamin—MUT—neck—melanoma	0.00215	0.0604	CbGeAlD
Hydroxocobalamin—CASP9—eye—melanoma	0.00209	0.0585	CbGeAlD
Hydroxocobalamin—MMACHC—head—melanoma	0.00206	0.0578	CbGeAlD
Hydroxocobalamin—TCN2—eye—melanoma	0.00204	0.0571	CbGeAlD
Hydroxocobalamin—TCN1—mammalian vulva—melanoma	0.0018	0.0504	CbGeAlD
Hydroxocobalamin—MUT—eye—melanoma	0.0016	0.0449	CbGeAlD
Hydroxocobalamin—MMAA—head—melanoma	0.00135	0.0379	CbGeAlD
Hydroxocobalamin—TCN1—head—melanoma	0.00129	0.0361	CbGeAlD
Hydroxocobalamin—MUT—mammalian vulva—melanoma	0.00127	0.0356	CbGeAlD
Hydroxocobalamin—MMAB—head—melanoma	0.00127	0.0355	CbGeAlD
Hydroxocobalamin—MTR—eye—melanoma	0.00126	0.0352	CbGeAlD
Hydroxocobalamin—Folliculitis—Dactinomycin—melanoma	0.00125	0.0187	CcSEcCtD
Hydroxocobalamin—Bullous eruption—Docetaxel—melanoma	0.0012	0.0179	CcSEcCtD
Hydroxocobalamin—AMN—lymph node—melanoma	0.00119	0.0333	CbGeAlD
Hydroxocobalamin—CASP9—head—melanoma	0.00118	0.0332	CbGeAlD
Hydroxocobalamin—TCN2—head—melanoma	0.00116	0.0324	CbGeAlD
Hydroxocobalamin—MTRR—mammalian vulva—melanoma	0.00114	0.032	CbGeAlD
Hydroxocobalamin—Thrombosis—Carmustine—melanoma	0.00104	0.0155	CcSEcCtD
Hydroxocobalamin—Lung disorder—Temozolomide—melanoma	0.001	0.015	CcSEcCtD
Hydroxocobalamin—CUBN—lymph node—melanoma	0.001	0.0281	CbGeAlD
Hydroxocobalamin—MTR—mammalian vulva—melanoma	0.000996	0.0279	CbGeAlD
Hydroxocobalamin—Extravasation—Bleomycin—melanoma	0.000966	0.0144	CcSEcCtD
Hydroxocobalamin—MMAA—lymph node—melanoma	0.000946	0.0265	CbGeAlD
Hydroxocobalamin—MUT—head—melanoma	0.000909	0.0255	CbGeAlD
Hydroxocobalamin—Memory impairment—Temozolomide—melanoma	0.000906	0.0135	CcSEcCtD
Hydroxocobalamin—Extravasation—Dactinomycin—melanoma	0.000901	0.0134	CcSEcCtD
Hydroxocobalamin—MMAB—lymph node—melanoma	0.000888	0.0249	CbGeAlD
Hydroxocobalamin—Extravasation—Carmustine—melanoma	0.000844	0.0126	CcSEcCtD
Hydroxocobalamin—CASP9—lymph node—melanoma	0.000829	0.0232	CbGeAlD
Hydroxocobalamin—MTRR—head—melanoma	0.000817	0.0229	CbGeAlD
Hydroxocobalamin—TCN2—lymph node—melanoma	0.000809	0.0227	CbGeAlD
Hydroxocobalamin—Injection site reaction—Carmustine—melanoma	0.000732	0.0109	CcSEcCtD
Hydroxocobalamin—MTR—head—melanoma	0.000713	0.02	CbGeAlD
Hydroxocobalamin—Phlebitis—Bleomycin—melanoma	0.000711	0.0106	CcSEcCtD
Hydroxocobalamin—Redness—Docetaxel—melanoma	0.000701	0.0105	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Vemurafenib—melanoma	0.000689	0.0103	CcSEcCtD
Hydroxocobalamin—Phlebitis—Dactinomycin—melanoma	0.000663	0.00989	CcSEcCtD
Hydroxocobalamin—Eye disorder—Vemurafenib—melanoma	0.000653	0.00974	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Vemurafenib—melanoma	0.000649	0.00968	CcSEcCtD
Hydroxocobalamin—MUT—lymph node—melanoma	0.000637	0.0178	CbGeAlD
Hydroxocobalamin—Angiopathy—Vemurafenib—melanoma	0.000634	0.00946	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Vemurafenib—melanoma	0.00063	0.0094	CcSEcCtD
Hydroxocobalamin—Chills—Vemurafenib—melanoma	0.000627	0.00936	CcSEcCtD
Hydroxocobalamin—Phlebitis—Carmustine—melanoma	0.00062	0.00925	CcSEcCtD
Hydroxocobalamin—Pleural effusion—Docetaxel—melanoma	0.000618	0.00922	CcSEcCtD
Hydroxocobalamin—Erythema—Vemurafenib—melanoma	0.000608	0.00908	CcSEcCtD
Hydroxocobalamin—Swelling—Carmustine—melanoma	0.000606	0.00904	CcSEcCtD
Hydroxocobalamin—MTRR—lymph node—melanoma	0.000572	0.016	CbGeAlD
Hydroxocobalamin—Hot flush—Temozolomide—melanoma	0.000552	0.00823	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Temozolomide—melanoma	0.000547	0.00816	CcSEcCtD
Hydroxocobalamin—Extravasation—Docetaxel—melanoma	0.000542	0.00809	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Carmustine—melanoma	0.000536	0.008	CcSEcCtD
Hydroxocobalamin—Chest discomfort—Docetaxel—melanoma	0.000535	0.00798	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000514	0.00767	CcSEcCtD
Hydroxocobalamin—MTR—lymph node—melanoma	0.000499	0.014	CbGeAlD
Hydroxocobalamin—Anaphylactic shock—Vemurafenib—melanoma	0.000497	0.00741	CcSEcCtD
Hydroxocobalamin—Dysphagia—Dactinomycin—melanoma	0.000493	0.00736	CcSEcCtD
Hydroxocobalamin—Infection—Vemurafenib—melanoma	0.000493	0.00736	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Vemurafenib—melanoma	0.000487	0.00727	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Carmustine—melanoma	0.000486	0.00725	CcSEcCtD
Hydroxocobalamin—Skin disorder—Vemurafenib—melanoma	0.000482	0.0072	CcSEcCtD
Hydroxocobalamin—Blood pressure increased—Docetaxel—melanoma	0.000473	0.00706	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Docetaxel—melanoma	0.00047	0.00702	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Temozolomide—melanoma	0.00047	0.00701	CcSEcCtD
Hydroxocobalamin—Dysphagia—Carmustine—melanoma	0.000462	0.00689	CcSEcCtD
Hydroxocobalamin—Dysphagia—Temozolomide—melanoma	0.000446	0.00666	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Vemurafenib—melanoma	0.000429	0.0064	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Docetaxel—melanoma	0.000421	0.00628	CcSEcCtD
Hydroxocobalamin—Phlebitis—Docetaxel—melanoma	0.000399	0.00595	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Vemurafenib—melanoma	0.000393	0.00586	CcSEcCtD
Hydroxocobalamin—Swelling—Docetaxel—melanoma	0.000389	0.00581	CcSEcCtD
Hydroxocobalamin—Chills—Bleomycin—melanoma	0.00038	0.00567	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Docetaxel—melanoma	0.000379	0.00565	CcSEcCtD
Hydroxocobalamin—Erythema—Bleomycin—melanoma	0.000369	0.0055	CcSEcCtD
Hydroxocobalamin—Hot flush—Docetaxel—melanoma	0.000367	0.00548	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Vemurafenib—melanoma	0.000366	0.00546	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Carmustine—melanoma	0.000364	0.00543	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Docetaxel—melanoma	0.000364	0.00543	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Docetaxel—melanoma	0.000359	0.00536	CcSEcCtD
Hydroxocobalamin—Chills—Dactinomycin—melanoma	0.000354	0.00529	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Temozolomide—melanoma	0.000353	0.00526	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Temozolomide—melanoma	0.000352	0.00525	CcSEcCtD
Hydroxocobalamin—Pruritus—Vemurafenib—melanoma	0.000351	0.00524	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Temozolomide—melanoma	0.00035	0.00522	CcSEcCtD
Hydroxocobalamin—Eye disorder—Carmustine—melanoma	0.000345	0.00515	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Docetaxel—melanoma	0.000345	0.00514	CcSEcCtD
Hydroxocobalamin—Erythema—Dactinomycin—melanoma	0.000344	0.00513	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Bleomycin—melanoma	0.000342	0.0051	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Vemurafenib—melanoma	0.00034	0.00507	CcSEcCtD
Hydroxocobalamin—Eye disorder—Temozolomide—melanoma	0.000334	0.00498	CcSEcCtD
Hydroxocobalamin—Malaise—Bleomycin—melanoma	0.000332	0.00496	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Temozolomide—melanoma	0.000332	0.00495	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Carmustine—melanoma	0.00033	0.00493	CcSEcCtD
Hydroxocobalamin—Dizziness—Vemurafenib—melanoma	0.000328	0.0049	CcSEcCtD
Hydroxocobalamin—Angiopathy—Temozolomide—melanoma	0.000324	0.00484	CcSEcCtD
Hydroxocobalamin—Mental disorder—Carmustine—melanoma	0.000324	0.00483	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Temozolomide—melanoma	0.000323	0.00481	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Temozolomide—melanoma	0.000322	0.0048	CcSEcCtD
Hydroxocobalamin—Erythema—Carmustine—melanoma	0.000322	0.0048	CcSEcCtD
Hydroxocobalamin—Chills—Temozolomide—melanoma	0.000321	0.00478	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Dactinomycin—melanoma	0.000319	0.00476	CcSEcCtD
Hydroxocobalamin—Chest pain—Bleomycin—melanoma	0.000314	0.00468	CcSEcCtD
Hydroxocobalamin—Rash—Vemurafenib—melanoma	0.000313	0.00467	CcSEcCtD
Hydroxocobalamin—Mental disorder—Temozolomide—melanoma	0.000313	0.00467	CcSEcCtD
Hydroxocobalamin—Dermatitis—Vemurafenib—melanoma	0.000313	0.00467	CcSEcCtD
Hydroxocobalamin—Headache—Vemurafenib—melanoma	0.000311	0.00464	CcSEcCtD
Hydroxocobalamin—Erythema—Temozolomide—melanoma	0.000311	0.00464	CcSEcCtD
Hydroxocobalamin—Discomfort—Bleomycin—melanoma	0.00031	0.00463	CcSEcCtD
Hydroxocobalamin—Malaise—Dactinomycin—melanoma	0.00031	0.00463	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Bleomycin—melanoma	0.000301	0.00449	CcSEcCtD
Hydroxocobalamin—Oedema—Bleomycin—melanoma	0.000301	0.00449	CcSEcCtD
Hydroxocobalamin—Infection—Bleomycin—melanoma	0.000299	0.00446	CcSEcCtD
Hydroxocobalamin—Dysphagia—Docetaxel—melanoma	0.000297	0.00443	CcSEcCtD
Hydroxocobalamin—Agitation—Carmustine—melanoma	0.000296	0.00441	CcSEcCtD
Hydroxocobalamin—Nausea—Vemurafenib—melanoma	0.000295	0.0044	CcSEcCtD
Hydroxocobalamin—Discomfort—Dactinomycin—melanoma	0.000289	0.00431	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Temozolomide—melanoma	0.000289	0.0043	CcSEcCtD
Hydroxocobalamin—Agitation—Temozolomide—melanoma	0.000286	0.00426	CcSEcCtD
Hydroxocobalamin—Angioedema—Temozolomide—melanoma	0.000284	0.00424	CcSEcCtD
Hydroxocobalamin—Oedema—Dactinomycin—melanoma	0.000281	0.00419	CcSEcCtD
Hydroxocobalamin—Malaise—Temozolomide—melanoma	0.00028	0.00418	CcSEcCtD
Hydroxocobalamin—Infection—Dactinomycin—melanoma	0.000279	0.00416	CcSEcCtD
Hydroxocobalamin—Chest pain—Carmustine—melanoma	0.000274	0.00409	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Bleomycin—melanoma	0.000268	0.004	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000263	0.00392	CcSEcCtD
Hydroxocobalamin—Oedema—Carmustine—melanoma	0.000263	0.00392	CcSEcCtD
Hydroxocobalamin—Discomfort—Temozolomide—melanoma	0.000262	0.0039	CcSEcCtD
Hydroxocobalamin—Infection—Carmustine—melanoma	0.000261	0.00389	CcSEcCtD
Hydroxocobalamin—Pain—Bleomycin—melanoma	0.000257	0.00384	CcSEcCtD
Hydroxocobalamin—Tachycardia—Carmustine—melanoma	0.000256	0.00382	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Temozolomide—melanoma	0.000254	0.00379	CcSEcCtD
Hydroxocobalamin—Oedema—Temozolomide—melanoma	0.000254	0.00379	CcSEcCtD
Hydroxocobalamin—Infection—Temozolomide—melanoma	0.000252	0.00376	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Temozolomide—melanoma	0.000249	0.00371	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Bleomycin—melanoma	0.000248	0.0037	CcSEcCtD
Hydroxocobalamin—Skin disorder—Temozolomide—melanoma	0.000247	0.00368	CcSEcCtD
Hydroxocobalamin—Pain—Dactinomycin—melanoma	0.00024	0.00358	CcSEcCtD
Hydroxocobalamin—Urticaria—Bleomycin—melanoma	0.000239	0.00357	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Bleomycin—melanoma	0.000238	0.00355	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Docetaxel—melanoma	0.000235	0.0035	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Carmustine—melanoma	0.000234	0.00349	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Docetaxel—melanoma	0.000234	0.00349	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Docetaxel—melanoma	0.000233	0.00347	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Dactinomycin—melanoma	0.000231	0.00345	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Carmustine—melanoma	0.000227	0.00338	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Temozolomide—melanoma	0.000226	0.00338	CcSEcCtD
Hydroxocobalamin—Pain—Carmustine—melanoma	0.000225	0.00335	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Temozolomide—melanoma	0.000223	0.00333	CcSEcCtD
Hydroxocobalamin—Eye disorder—Docetaxel—melanoma	0.000222	0.00331	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Dactinomycin—melanoma	0.000222	0.00331	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Bleomycin—melanoma	0.000222	0.00331	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Docetaxel—melanoma	0.00022	0.00329	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Temozolomide—melanoma	0.000219	0.00327	CcSEcCtD
Hydroxocobalamin—Pain—Temozolomide—melanoma	0.000217	0.00324	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Carmustine—melanoma	0.000216	0.00323	CcSEcCtD
Hydroxocobalamin—Angiopathy—Docetaxel—melanoma	0.000216	0.00322	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Docetaxel—melanoma	0.000215	0.0032	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Docetaxel—melanoma	0.000214	0.00319	CcSEcCtD
Hydroxocobalamin—Chills—Docetaxel—melanoma	0.000213	0.00318	CcSEcCtD
Hydroxocobalamin—Pruritus—Bleomycin—melanoma	0.000213	0.00318	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Docetaxel—melanoma	0.000212	0.00317	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Temozolomide—melanoma	0.000209	0.00312	CcSEcCtD
Hydroxocobalamin—Mental disorder—Docetaxel—melanoma	0.000208	0.0031	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Carmustine—melanoma	0.000208	0.0031	CcSEcCtD
Hydroxocobalamin—Erythema—Docetaxel—melanoma	0.000207	0.00309	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Dactinomycin—melanoma	0.000207	0.00308	CcSEcCtD
Hydroxocobalamin—Urticaria—Temozolomide—melanoma	0.000202	0.00301	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Temozolomide—melanoma	0.000201	0.00299	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Carmustine—melanoma	0.000193	0.00289	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Dactinomycin—melanoma	0.000192	0.00286	CcSEcCtD
Hydroxocobalamin—Rash—Bleomycin—melanoma	0.00019	0.00283	CcSEcCtD
Hydroxocobalamin—Dermatitis—Bleomycin—melanoma	0.00019	0.00283	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Temozolomide—melanoma	0.000187	0.00279	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Carmustine—melanoma	0.00018	0.00268	CcSEcCtD
Hydroxocobalamin—Pruritus—Temozolomide—melanoma	0.00018	0.00268	CcSEcCtD
Hydroxocobalamin—Nausea—Bleomycin—melanoma	0.000179	0.00267	CcSEcCtD
Hydroxocobalamin—Rash—Dactinomycin—melanoma	0.000177	0.00264	CcSEcCtD
Hydroxocobalamin—Chest pain—Docetaxel—melanoma	0.000176	0.00263	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000175	0.00261	CcSEcCtD
Hydroxocobalamin—Dizziness—Carmustine—melanoma	0.000174	0.00259	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Temozolomide—melanoma	0.000174	0.00259	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Docetaxel—melanoma	0.000169	0.00252	CcSEcCtD
Hydroxocobalamin—Oedema—Docetaxel—melanoma	0.000169	0.00252	CcSEcCtD
Hydroxocobalamin—Dizziness—Temozolomide—melanoma	0.000168	0.0025	CcSEcCtD
Hydroxocobalamin—Infection—Docetaxel—melanoma	0.000168	0.0025	CcSEcCtD
Hydroxocobalamin—Nausea—Dactinomycin—melanoma	0.000167	0.00249	CcSEcCtD
Hydroxocobalamin—Rash—Carmustine—melanoma	0.000166	0.00247	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Docetaxel—melanoma	0.000166	0.00247	CcSEcCtD
Hydroxocobalamin—Dermatitis—Carmustine—melanoma	0.000165	0.00247	CcSEcCtD
Hydroxocobalamin—Tachycardia—Docetaxel—melanoma	0.000165	0.00246	CcSEcCtD
Hydroxocobalamin—Headache—Carmustine—melanoma	0.000165	0.00245	CcSEcCtD
Hydroxocobalamin—Skin disorder—Docetaxel—melanoma	0.000164	0.00245	CcSEcCtD
Hydroxocobalamin—Rash—Temozolomide—melanoma	0.00016	0.00239	CcSEcCtD
Hydroxocobalamin—Dermatitis—Temozolomide—melanoma	0.00016	0.00239	CcSEcCtD
Hydroxocobalamin—Headache—Temozolomide—melanoma	0.000159	0.00237	CcSEcCtD
Hydroxocobalamin—Nausea—Carmustine—melanoma	0.000156	0.00233	CcSEcCtD
Hydroxocobalamin—Nausea—Temozolomide—melanoma	0.000151	0.00225	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Docetaxel—melanoma	0.00015	0.00224	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Docetaxel—melanoma	0.000149	0.00222	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Docetaxel—melanoma	0.000146	0.00217	CcSEcCtD
Hydroxocobalamin—Pain—Docetaxel—melanoma	0.000144	0.00215	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Docetaxel—melanoma	0.000139	0.00207	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Docetaxel—melanoma	0.000133	0.00199	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Docetaxel—melanoma	0.000124	0.00186	CcSEcCtD
Hydroxocobalamin—Pruritus—Docetaxel—melanoma	0.000119	0.00178	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Docetaxel—melanoma	0.000115	0.00172	CcSEcCtD
Hydroxocobalamin—Dizziness—Docetaxel—melanoma	0.000112	0.00166	CcSEcCtD
Hydroxocobalamin—Rash—Docetaxel—melanoma	0.000106	0.00159	CcSEcCtD
Hydroxocobalamin—Dermatitis—Docetaxel—melanoma	0.000106	0.00159	CcSEcCtD
Hydroxocobalamin—Headache—Docetaxel—melanoma	0.000106	0.00158	CcSEcCtD
Hydroxocobalamin—Nausea—Docetaxel—melanoma	0.0001	0.0015	CcSEcCtD
Hydroxocobalamin—MUT—Disease—MYC—melanoma	1.02e-05	5.88e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PTEN—melanoma	1.02e-05	5.88e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PIK3CA—melanoma	1.02e-05	5.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—NFKB1—melanoma	1.01e-05	5.85e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—TLR4—melanoma	1.01e-05	5.84e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—HRAS—melanoma	1.01e-05	5.84e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—HRAS—melanoma	1.01e-05	5.84e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MAP2K1—melanoma	1.01e-05	5.84e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—STAT3—melanoma	1.01e-05	5.84e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HLA-DRB1—melanoma	1.01e-05	5.84e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NRAS—melanoma	1.01e-05	5.82e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CDKN1B—melanoma	1.01e-05	5.82e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CD—melanoma	1e-05	5.8e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PIK3CA—melanoma	1e-05	5.78e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MAPK1—melanoma	9.95e-06	5.75e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—EGFR—melanoma	9.95e-06	5.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SYK—melanoma	9.95e-06	5.75e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KRAS—melanoma	9.85e-06	5.69e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—KRAS—melanoma	9.85e-06	5.69e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NGFR—melanoma	9.76e-06	5.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT3—melanoma	9.76e-06	5.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ITGAV—melanoma	9.76e-06	5.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HIF1A—melanoma	9.76e-06	5.64e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—AKT1—melanoma	9.76e-06	5.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ICAM1—melanoma	9.69e-06	5.6e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—IL6—melanoma	9.67e-06	5.59e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—IL6—melanoma	9.67e-06	5.59e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MAPK3—melanoma	9.65e-06	5.58e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—FGF2—melanoma	9.61e-06	5.56e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CG—melanoma	9.56e-06	5.53e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CTNNB1—melanoma	9.52e-06	5.5e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTEN—melanoma	9.46e-06	5.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—NRAS—melanoma	9.45e-06	5.46e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KRAS—melanoma	9.4e-06	5.43e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—HRAS—melanoma	9.4e-06	5.43e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MYC—melanoma	9.39e-06	5.43e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD80—melanoma	9.33e-06	5.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KIT—melanoma	9.31e-06	5.38e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CDKN1A—melanoma	9.3e-06	5.37e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTEN—melanoma	9.28e-06	5.36e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PPARG—melanoma	9.23e-06	5.34e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGF—melanoma	9.21e-06	5.32e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MAPK1—melanoma	9.18e-06	5.31e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—EGFR—melanoma	9.18e-06	5.31e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PIK3CA—melanoma	9.15e-06	5.29e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PIK3CA—melanoma	9.15e-06	5.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—NRAS—melanoma	9.07e-06	5.24e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PIK3CA—melanoma	9.05e-06	5.23e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PIK3CA—melanoma	9.05e-06	5.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MAPK3—melanoma	9.05e-06	5.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SOCS1—melanoma	9.04e-06	5.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—S100B—melanoma	9.02e-06	5.21e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MDM2—melanoma	8.99e-06	5.2e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—IL6—melanoma	8.99e-06	5.2e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CB—melanoma	8.99e-06	5.2e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—AKT1—melanoma	8.92e-06	5.16e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—AKT1—melanoma	8.92e-06	5.16e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTGS2—melanoma	8.91e-06	5.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOS2—melanoma	8.88e-06	5.13e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—ERBB2—melanoma	8.87e-06	5.13e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOTCH1—melanoma	8.79e-06	5.08e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CB—melanoma	8.75e-06	5.06e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CD4—melanoma	8.74e-06	5.05e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KRAS—melanoma	8.67e-06	5.01e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CASP8—melanoma	8.67e-06	5.01e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTGS2—melanoma	8.67e-06	5.01e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PIK3CA—melanoma	8.64e-06	4.99e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ERBB4—melanoma	8.62e-06	4.98e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CD80—melanoma	8.61e-06	4.98e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MAPK1—melanoma	8.61e-06	4.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EGFR—melanoma	8.61e-06	4.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—APC—melanoma	8.6e-06	4.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KIT—melanoma	8.6e-06	4.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDH1—melanoma	8.57e-06	4.95e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN2B—melanoma	8.55e-06	4.94e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PIK3CA—melanoma	8.51e-06	4.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGF—melanoma	8.5e-06	4.91e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CD—melanoma	8.41e-06	4.86e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HRAS—melanoma	8.37e-06	4.84e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HRAS—melanoma	8.37e-06	4.84e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ALB—melanoma	8.3e-06	4.8e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—AKT1—melanoma	8.3e-06	4.8e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—STAT3—melanoma	8.3e-06	4.8e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NRAS—melanoma	8.28e-06	4.78e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CD86—melanoma	8.27e-06	4.78e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—EGFR—melanoma	8.26e-06	4.78e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MAP2K1—melanoma	8.24e-06	4.76e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDKN1B—melanoma	8.21e-06	4.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EDN1—melanoma	8.2e-06	4.74e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CD—melanoma	8.19e-06	4.73e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—AKT1—melanoma	8.17e-06	4.72e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KRAS—melanoma	8.13e-06	4.7e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—BRAF—melanoma	8.08e-06	4.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGF1—melanoma	8.02e-06	4.63e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CSF2—melanoma	8.02e-06	4.63e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—IL6—melanoma	8.02e-06	4.63e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—IL6—melanoma	8.02e-06	4.63e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HRAS—melanoma	7.99e-06	4.62e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PIK3CA—melanoma	7.97e-06	4.61e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MAPK3—melanoma	7.93e-06	4.58e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—E2F1—melanoma	7.85e-06	4.54e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FGF2—melanoma	7.84e-06	4.53e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KRAS—melanoma	7.81e-06	4.51e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTEN—melanoma	7.77e-06	4.49e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PDGFRA—melanoma	7.77e-06	4.49e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CTNNB1—melanoma	7.76e-06	4.48e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MYC—melanoma	7.71e-06	4.46e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ITGB3—melanoma	7.69e-06	4.44e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PRKCA—melanoma	7.69e-06	4.44e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—IL6—melanoma	7.65e-06	4.42e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MAP2K1—melanoma	7.61e-06	4.4e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PIK3CA—melanoma	7.58e-06	4.38e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PIK3CA—melanoma	7.58e-06	4.38e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDKN1A—melanoma	7.58e-06	4.38e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTEN—melanoma	7.56e-06	4.37e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CD—melanoma	7.56e-06	4.37e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MAPK1—melanoma	7.54e-06	4.36e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EGFR—melanoma	7.54e-06	4.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SPP1—melanoma	7.54e-06	4.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAP2K2—melanoma	7.51e-06	4.34e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—AKT1—melanoma	7.47e-06	4.32e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—AKT1—melanoma	7.47e-06	4.32e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PIK3CA—melanoma	7.47e-06	4.32e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—BCL2—melanoma	7.44e-06	4.3e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—AKT1—melanoma	7.39e-06	4.27e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—AKT1—melanoma	7.39e-06	4.27e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IFNG—melanoma	7.38e-06	4.26e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—HRAS—melanoma	7.37e-06	4.26e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MDM2—melanoma	7.33e-06	4.24e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CB—melanoma	7.33e-06	4.24e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS2—melanoma	7.26e-06	4.2e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FGF2—melanoma	7.24e-06	4.18e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PIK3CA—melanoma	7.23e-06	4.18e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ERBB2—melanoma	7.23e-06	4.18e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PIK3CA—melanoma	7.17e-06	4.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TERT—melanoma	7.15e-06	4.13e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CB—melanoma	7.14e-06	4.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RAC1—melanoma	7.13e-06	4.12e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KRAS—melanoma	7.12e-06	4.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD4—melanoma	7.12e-06	4.12e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—IL6—melanoma	7.06e-06	4.08e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—AKT1—melanoma	7.05e-06	4.08e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—AKT1—melanoma	6.95e-06	4.02e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—HRAS—melanoma	6.91e-06	3.99e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HIF1A—melanoma	6.83e-06	3.95e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MDM2—melanoma	6.77e-06	3.91e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—STAT3—melanoma	6.76e-06	3.91e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NRAS—melanoma	6.75e-06	3.9e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDKN1B—melanoma	6.7e-06	3.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ERBB2—melanoma	6.68e-06	3.86e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CA—melanoma	6.67e-06	3.86e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—HRAS—melanoma	6.64e-06	3.84e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—IL6—melanoma	6.61e-06	3.82e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CB—melanoma	6.59e-06	3.81e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CD4—melanoma	6.58e-06	3.8e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL2—melanoma	6.55e-06	3.79e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CA—melanoma	6.54e-06	3.78e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KDR—melanoma	6.54e-06	3.78e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTGS2—melanoma	6.53e-06	3.77e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—AKT1—melanoma	6.51e-06	3.76e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MAPK3—melanoma	6.46e-06	3.73e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTEN—melanoma	6.33e-06	3.66e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CTNNB1—melanoma	6.33e-06	3.66e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FN1—melanoma	6.29e-06	3.64e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MYC—melanoma	6.28e-06	3.63e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—AKT1—melanoma	6.19e-06	3.58e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—AKT1—melanoma	6.19e-06	3.58e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN1B—melanoma	6.18e-06	3.57e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDKN1A—melanoma	6.18e-06	3.57e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PTEN—melanoma	6.17e-06	3.56e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOTCH1—melanoma	6.16e-06	3.56e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MAPK1—melanoma	6.15e-06	3.55e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EGFR—melanoma	6.15e-06	3.55e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NFKB1—melanoma	6.14e-06	3.55e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—AKT1—melanoma	6.1e-06	3.53e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—HRAS—melanoma	6.05e-06	3.5e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CD80—melanoma	6.03e-06	3.49e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KIT—melanoma	6.02e-06	3.48e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APC—melanoma	6.02e-06	3.48e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CG—melanoma	6.02e-06	3.48e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGF—melanoma	5.95e-06	3.44e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—AKT1—melanoma	5.91e-06	3.41e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—AKT1—melanoma	5.86e-06	3.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CTNNB1—melanoma	5.84e-06	3.38e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KRAS—melanoma	5.81e-06	3.36e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—IL6—melanoma	5.79e-06	3.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN1A—melanoma	5.71e-06	3.3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTEN—melanoma	5.69e-06	3.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—BRAF—melanoma	5.66e-06	3.27e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—STAT3—melanoma	5.51e-06	3.19e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF1—melanoma	5.51e-06	3.19e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NRAS—melanoma	5.5e-06	3.18e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CA—melanoma	5.48e-06	3.17e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—AKT1—melanoma	5.45e-06	3.15e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—AKT1—melanoma	5.35e-06	3.09e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CA—melanoma	5.33e-06	3.08e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAP2K1—melanoma	5.33e-06	3.08e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CD—melanoma	5.29e-06	3.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MAPK3—melanoma	5.27e-06	3.05e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—STAT3—melanoma	5.09e-06	2.94e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NRAS—melanoma	5.08e-06	2.94e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGF2—melanoma	5.07e-06	2.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MAPK1—melanoma	5.01e-06	2.9e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGFR—melanoma	5.01e-06	2.9e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HRAS—melanoma	4.94e-06	2.85e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MAPK3—melanoma	4.86e-06	2.81e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MDM2—melanoma	4.74e-06	2.74e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KRAS—melanoma	4.73e-06	2.74e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MYC—melanoma	4.73e-06	2.73e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IL6—melanoma	4.72e-06	2.73e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ERBB2—melanoma	4.68e-06	2.7e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MAPK1—melanoma	4.63e-06	2.68e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGFR—melanoma	4.63e-06	2.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CB—melanoma	4.61e-06	2.67e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AKT1—melanoma	4.48e-06	2.59e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CA—melanoma	4.47e-06	2.58e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCL8—melanoma	4.43e-06	2.56e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KRAS—melanoma	4.37e-06	2.53e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT1—melanoma	4.36e-06	2.52e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CA—melanoma	4.35e-06	2.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN1B—melanoma	4.33e-06	2.5e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CASP3—melanoma	4.24e-06	2.45e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL2—melanoma	4.24e-06	2.45e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCND1—melanoma	4.13e-06	2.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CTNNB1—melanoma	4.09e-06	2.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—HRAS—melanoma	4.02e-06	2.33e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CA—melanoma	4.02e-06	2.32e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP9—melanoma	4.01e-06	2.32e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN1A—melanoma	4e-06	2.31e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTEN—melanoma	3.99e-06	2.3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NFKB1—melanoma	3.97e-06	2.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL6—melanoma	3.85e-06	2.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HRAS—melanoma	3.72e-06	2.15e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AKT1—melanoma	3.65e-06	2.11e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—melanoma	3.6e-06	2.08e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STAT3—melanoma	3.57e-06	2.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NRAS—melanoma	3.56e-06	2.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IL6—melanoma	3.56e-06	2.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT1—melanoma	3.55e-06	2.05e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAPK3—melanoma	3.41e-06	1.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MYC—melanoma	3.31e-06	1.91e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT1—melanoma	3.28e-06	1.9e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAPK1—melanoma	3.24e-06	1.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGFR—melanoma	3.24e-06	1.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KRAS—melanoma	3.06e-06	1.77e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CA—melanoma	2.81e-06	1.63e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—melanoma	2.72e-06	1.57e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HRAS—melanoma	2.6e-06	1.5e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL6—melanoma	2.49e-06	1.44e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT1—melanoma	2.3e-06	1.33e-05	CbGpPWpGaD
